S-3 GROUP

Lobbying for AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC. · Biopharmaceutical development

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income · posted Apr 17, 2026

Bills named in this filing 2

Lobbying activity 2

Health Issues

H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019

Budget/Appropriations

Issues related to health care research

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.